Mechanistic insights and perspectives involved in neuroprotective action of quercetin AK Grewal, TG Singh, D Sharma, V Sharma, M Singh, MH Rahman, ... Biomedicine & Pharmacotherapy 140, 111729, 2021 | 152 | 2021 |
Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets. Thapa, K., Khan, H., Singh, T.G. and Kaur, A. Journal of Molecular Neuroscience, pp.1-18, 2021 | 148* | 2021 |
Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease. TG Sharma, V., Kaur, A. and Singh Biomedicine & Pharmacotherapy, p.110373., 2020 | 74 | 2020 |
Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases K Thapa, H Khan, U Sharma, AK Grewal, TG Singh Life Sciences 267, 118975, 2021 | 58 | 2021 |
Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling A Sharma, H Khan, TG Singh, AK Grewal, A Najda, ... International Journal of Molecular Sciences 22 (21), 11971, 2021 | 45 | 2021 |
Sirtuin acetylation and deacetylation: a complex paradigm in neurodegenerative disease. TG Khan, H., Tiwari, P., Kaur, A. and Singh Molecular Neurobiology, pp.1-15., 2021 | 45* | 2021 |
Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury H Khan, K Sharma, A Kumar, A Kaur, TG Singh Inflammation Research 71 (3), 277-292, 2022 | 43 | 2022 |
Therapeutic insights on ferroptosis in Parkinson's disease K Thapa, H Khan, N Kanojia, TG Singh, A Kaur, G Kaur European Journal of Pharmacology 930, 175133, 2022 | 40 | 2022 |
Neuropeptides: Potential neuroprotective agents in ischemic injury. 47. Saklani, P., Khan, H., Gupta, S., Kaur, A. and Singh, T.G. Life Sciences., p.120186., 2021 | 38* | 2021 |
Therapeutic modulation of the phosphatidylinositol 3-kinases (PI3K) pathway in cerebral ischemic injury H Khan, A Singh, K Thapa, N Garg, AK Grewal, TG Singh Brain Research 1761, 147399, 2021 | 37 | 2021 |
Mechanistic insight on the role of leukotriene receptors in ischemic–reperfusion injury A 41. Khan, H., Gupta, A., Singh, T.G. and Kaur Pharmacological Reports,, pp.1-15., 2021 | 37* | 2021 |
Effects of resveratrol postconditioning on cerebral ischemia in mice: role of the sirtuin-1 pathway AK Grewal, N Singh, TG Singh Canadian journal of physiology and pharmacology 97 (11), 1094-1101, 2019 | 34 | 2019 |
Pharmacological postconditioning: a molecular aspect in ischemic injury. TG Khan, H., Kashyap, A., Kaur, A. and Singh Journal of Pharmacy and Pharmacology, 2020 | 32 | 2020 |
Novel Targets Explored in the Treatment of Alcohol Withdrawal Syndrome. Gupta, A., Khan, H., Kaur, A. and Singh, T.G. CNS & Neurological Disorders-Drug Targets, 2020 | 30* | 2020 |
Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases. Khan, H., Garg, N., Singh, T.G., Kaur, A. and Thapa, K. Neurochemical Research, pp.1-25, 2022 | 29* | 2022 |
Therapies modulating insulin resistance in Parkinson’s disease: a cross talk. TG Sharma, T., Kaur, D., Grewal, A.K. and Singh Neuroscience Letters, p.135754., 2021 | 27 | 2021 |
Mechanistic Insight on Autophagy Modulated Molecular Pathways in Cerebral Ischemic Injury: From Preclinical to Clinical Perspective TG Kalra, P., Khan, H., Kaur, A. and Singh Neurochemical Research, pp.1-19, 2022 | 25 | 2022 |
Brain-derived neurotrophic factor: a novel dynamically regulated therapeutic modulator in neurological disorders V Sharma, TG Singh, A Kaur, A Mannan, S Dhiman Neurochemical Research 48 (2), 317-339, 2023 | 24 | 2023 |
Intervention of neuroinflammation in the traumatic brain injury trajectory: In vivo and clinical approaches NK Prabhakar, H Khan, AK Grewal, TG Singh International Immunopharmacology 108, 108902, 2022 | 23 | 2022 |
Caspase-mediated regulation of the distinct signaling pathways and mechanisms in neuronal survival H Khan, A Bangar, AK Grewal, P Bansal, TG Singh International Immunopharmacology 110, 108951, 2022 | 22 | 2022 |